Ceruloplasmin in Parkinson's disease and the nonmotor symptoms-Reference-Cited by-同舟云学术

Ceruloplasmin in Parkinson's disease and the nonmotor symptoms

Published:2018-05-07 Issue:6 Volume:8 Page:e00995
ISSN:2162-3279
Container-title:Brain and Behavior
language:en
Short-container-title:Brain Behav

Author:

Zhao Xuemei¹,Shao Ziqiang²^ORCID,Zhang Yu³,Liu Fang⁴,Liu Zhibo¹,Liu Zunjing²^ORCID

Affiliation:

1. Department of Radiology; The First Hospital of Tsinghua University; Beijing China

2. Department of Neurology; China-Japan Friendship Hospital; Beijing China

3. The School of Medicine; Tsinghua University; Beijing China

4. Department of Neurology; The First Hospital of Tsinghua University; Beijing China

Publisher

Wiley

Subject

Behavioral Neuroscience

Reference32 articles.

1. Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration;Ayton;BioMed Research International,2014

2. Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: Implications for Parkinson's disease;Ayton;Molecular Neurodegeneration,2014

3. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease;Bartzokis;Cellular and Molecular Biology,2000

4. Nocturnal symptom complex in PD and its management;Chaudhuri;Neurology,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferroptosis-related factors in the substantia nigra are associated with Parkinson’s disease;Scientific Reports;2023-09-16

2. Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s disease;npj Parkinson's Disease;2023-04-06

3. Estimation and Evaluation of (Uric Acid, Glutathione, Ceroplasmin) and the Trace Elements (Iron, Copper, Zinc) Levels in Type_2 Diabetic Patients in Basrah Governorate-Iraq;European Journal of Biomedical Research;2023-02-08

4. Exploring the Genetic and Genomic Connection Underlying Neurodegeneration with Brain Iron Accumulation and the Risk for Parkinson’s Disease;2022-09-29

5. Therapeutic Insights on Ferroptosis in Parkinson's disease;European Journal of Pharmacology;2022-09